Vanda Pharmaceuticals Inc. (VNDA)
VNDA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.30
-5.29% on the day
Market cap
$260.0M
Micro cap
Revenue · 2025
$216.1M
+8.7% on 2024
Net income · 2025
-$220.5M
-102.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | VNDA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2006 |
| SEC CIK | 0001347178 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $216.1M |
| Net income | -$220.5M |
| Operating income | -$151.2M |
| Net margin | -102.0% |
| Operating margin | -70.0% |
| Revenue growth | +8.7% |
| Cash | $84.9M |
| Total assets | $488.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-02-12 |
| Latest annual report | 10-K | 2026-02-12 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CATX | Perspective Therapeutics Inc. | $2.27 | -9.92% | $259.1M |
| ABEO | Abeona Therapeutics Inc. | $4.52 | -7.75% | $258.5M |
| BIOA | BioAge Labs Inc. | $5.57 | -6.23% | $255.6M |
| BCYC | Bicycle Therapeutics plc | $3.63 | -4.47% | $254.1M |
| RCKT | Rocket Pharmaceuticals Inc. | $2.30 | -7.26% | $252.5M |
| VOGX | Vogenx Inc | $16.76 | -2.22% | $249.0M |
| AMRN | Amarin Corporation plc | $11.58 | +0.43% | $244.6M |
| ACIU | AC Immune SA | $2.40 | -2.04% | $244.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier